Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale

Published:2009-12 Issue:11-12 Volume:30 Page:1159-1170
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

SPIEGEL B.,BOLUS R.,HARRIS L. A.,LUCAK S.,NALIBOFF B.,ESRAILIAN E.,CHEY W. D.,LEMBO A.,KARSAN H.,TILLISCH K.,TALLEY J.,MAYER E.,CHANG L.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2009.04144.x/fullpdf

Reference37 articles.

1. Functional bowel disorders;Longstreth;Gastroenterology,2006

2. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples;Whitehead;Gastroenterology,1990

3. Irritable bowel syndrome defined by factor analysis Gender and race comparisons;Taub;Dig Dis Sci,1995

4. Predictors of patient-assessed illness severity in irritable bowel syndrome;Spiegel;Am J Gastroenterol,2008

5. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome;Spiegel;Arch Intern Med,2004

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme;Journal of Crohn's and Colitis;2024-06-13

2. Assessing ‘response’ to the low-FODMAP diet in irritable bowel syndrome: Should we be reporting harder primary endpoints?;Clinical Nutrition;2024-05

3. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome;Gut Microbes;2024-04-17

4. Efficacy and safety of Changyanning tablets in the treatment of diarrhea-predominant irritable bowel syndrome and its effect on gut microbiota：Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial;2024-01-23

5. Effectiveness of an amino acid beverage formulation in diarrhea-predominant irritable bowel syndrome: A pragmatic real-world study;World Journal of Gastrointestinal Pharmacology and Therapeutics;2023-12-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3